Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 Q1- Text added to 2020 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Asuragen, capability, carrying, claim, compound, CTA, feasibility, free, Genotyping, HMRC, inducement, Kingdom, Listing, Majesty, manuscript, molecular, Nasdaq, onsite, oversaw, published, resurgence, scalable, titled, turnaround, upcoming, uptake, verify
Removed:
amend, evolution, GalNAc, guidance, half, laboratory, largest, metabolic, oversee, receipt, separation, space
Valuein 2020 Q1 filing- Value in 2020 Q2 filing
Original filings
Filing view